Truncating mutations in the tumour suppressor gene encoding APC are the most common cause of colorectal cancer. APC is a negative regulator of the Wnt signalling pathway, and constitutive activation of Wnt–β-catenin signalling is thought to form the basis of the oncogenic effects of APC mutations. However, recent evidence has suggested that other proteins could also be involved. Alexander Valvezan, Peter Klein and colleagues recently showed that APC suppresses mTORC1 activity in vitro. Here, the group explored the relationship between APC and mTORC1, a nutrient sensor that regulates cell growth and proliferation, in vivo. The authors show that mTORC1 activity is markedly upregulated in apc mutant zebrafish and in intestinal polyps in Apc mutant mice. mTORC1 inhibition suppressed multiple developmental defects caused by apc mutation in zebrafish. Interestingly, combined inhibition of mTORC1 and Wnt signalling was needed to restore normal body curvature. These findings suggest that mTORC1 is a key mediator of APC-driven tumorigenesis and developmental defects, and suggest mechanistic overlap with other polyposis syndromes that are associated with mTORC1 activation. Page 63
A nutrient-sensing pathway activated in APC-driven colorectal cancer Open Access
- Split-screen
- Views Icon Views Open Menu
- Open the PDF for in another window
-
Article Versions Icon
Versions
- Version of Record 01 January 2014
- Share Icon Share
-
Tools Icon
Tools
Open Menu
- Search Site
A nutrient-sensing pathway activated in APC-driven colorectal cancer. Dis Model Mech 1 January 2014; 7 (1): 1. doi:
Download citation file:
Advertisement
Cited by
Interviews with Biologists @ 100 conference speakers

Explore our interviews with keynote speakers from the Biologists @ 100 conference, hosted to celebrate our publisher’s 100th anniversary, where we discuss climate change and biodiversity with Hans-Otto Pörtner and Jane Francis, health and disease with Charles Swanton and Sadaf Farooqi, and emerging technologies with Manu Prakash and Jennifer Lippincott-Schwartz.
A new perspective on disease research
DMM publishes perspectives – peer-reviewed articles that provide expert analysis of a topic important to the disease research community. Read our collection from authors presenting new or potentially controversial ideas or hypotheses, to help address future challenges and forge new directions.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
History of our journals

As our publisher, The Company of Biologists, turns 100 years old, read about DMM’s history and explore the journey of each of our sister journals: Development, Journal of Cell Science, Journal of Experimental Biology and Biology Open.
Other journals from
The Company of Biologists